SILO
What one share of Silo Pharma holds
Pharmaceutical Preparations
We are focused on developing novel therapies that include conventional drugs and psychedelic
Silo Pharma’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.06 |
|---|---|
| Profit | −$5.07 |
| Cash and investments | $2.90 |
| Book value | $4.33 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2018 | — | −$14.81 | — | $4.16 | — | — |
| 2019 | $1.30 | −$30.00 | — | −$25.38 | — | −$0.73 |
| 2020 | $0.47 | −$37.50 | — | −$13.16 | — | $11.28 |
| 2021 | — | $30.52 | — | −$17.81 | — | $68.91 |
| 2022 | $0.47 | −$25.67 | — | −$22.97 | — | $49.10 |
| 2023 | $0.35 | −$18.02 | — | −$15.70 | — | $31.88 |
| 2024 | $0.29 | −$17.90 | — | −$15.63 | — | $16.84 |
| 2025 | $0.13 | −$7.57 | — | −$8.34 | — | $7.10 |